Toggle Main Menu Toggle Search

Open Access padlockePrints

Drug allergies documented in electronic health records of a large healthcare system

Lookup NU author(s): Professor Sarah SlightORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Background: The prevalence of drug allergies documented in electronic health records (EHRs) of large patient populations is understudied. Objective: We aimed to describe the prevalence of common drug allergies and patient characteristics documented in EHRs of a large healthcare network over the last two decades. Methods: Drug allergy data were obtained from EHRs of patients who visited two large tertiary care hospitals in Boston from 1990 to 2013. The prevalence of each drug and drug class was calculated and compared by sex and race/ethnicity. The number of allergies per patient was calculated and the frequency of patients having 1, 2, 3…, or 10+ drug allergies was reported. We also conducted a trend analysis by comparing the proportion of each allergy to the total number of drug allergies over time. Results: Among 1 766 328 patients, 35.5% of patients had at least one reported drug allergy with an average of 1.95 drug allergies per patient. The most commonly reported drug allergies in this population were to penicillins (12.8%), sulfonamide antibiotics (7.4%), opiates (6.8%), and nonsteroidal anti-inflammatory drugs (NSAIDs) (3.5%). The relative proportion of allergies to angiotensin-converting enzyme (ACE) inhibitors and HMG CoA reductase inhibitors (statins) have more than doubled since early 2000s. Drug allergies were most prevalent among females and white patients except for NSAIDs, ACE inhibitors, and thiazide diuretics, which were more prevalent in black patients. Conclusion: Females and white patients may be more likely to experience a reaction from common medications. An increase in reported allergies to ACE inhibitors and statins is noteworthy.


Publication metadata

Author(s): Zhou L, Dhopeshwarkar N, Blumenthal KG, Goss F, Topaz M, Slight SP, Bates DW

Publication type: Article

Publication status: Published

Journal: Allergy: European Journal of Allergy and Clinical Immunology

Year: 2016

Volume: 71

Issue: 9

Pages: 1305-1313

Print publication date: 01/09/2016

Online publication date: 06/04/2016

Acceptance date: 07/03/2016

ISSN (print): 0105-4538

ISSN (electronic): 1398-9995

Publisher: Blackwell Publishing Ltd

URL: https://doi.org/10.1111/all.12881

DOI: 10.1111/all.12881


Altmetrics

Altmetrics provided by Altmetric


Share